Electrical characterization of MXenes and their applications on photovoltaic cells

Ti3C2Tx is a particular type of MXene whose electrical properties have been studied. Specifically, its performance as a hole transport layer (HTL) in an n-type Si photovoltaic cell has been evaluated and compared to a cell without MXene. Additionally, a layer of a dipolar material, PAMAM, has been implemented alongside with MXene to improve the overall behaviour of the cell. J-V and EQE characteristics have been measured for the di↵erent cells and figures of merit have been computed to determine the e↵ect of adding layers of MXene and PAMAM. The measurements have been done at room temperature and after a 1002021/202

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens

Tonically active cholinergic interneurons (TANs) from the nucleus accumbens (NAc) are centrally involved in reward behavior. TANs express a vesicular glutamate transporter referred to as VGLUT3 and thus use both acetylcholine and glutamate as neurotransmitters. The respective roles of each transmitter in the regulation of reward and addiction are still unknown. In this study, we showed that disruption of the gene that encodes VGLUT3 (Slc17a8) markedly increased cocaine self-administration in mice. Concomitantly, the amount of dopamine (DA) release was strongly augmented in the NAc of VGLUT3(-/-) mice because of a lack of signaling by metabotropic glutamate receptors. Furthermore, dendritic spines and glutamatergic synaptic transmission on medium spiny neurons were increased in the NAc of VGLUT3(-/-) mice. Increased DA and glutamate signaling in the NAc are hallmarks of addiction. Our study shows that TANs use glutamate to reduce DA release and decrease reinforcing properties of cocaine in mice. Interestingly, we also observed an increased frequency of rare variations in SLC17A8 in a cohort of severe drug abusers compared with controls. Our findings identify VGLUT3 as an unexpected regulator of drug abuse.This research was supported by funds from ANR (ANR-09-MNPS-033, ANR-13-SAMA-0005-01), Équipe FRM DEQ20130326486, FRC, Brain Canada Multi-Investigator Research Initiative, Djavad Mowafaghian Foundation, ERANET-Neuron Joint Transnational Call for "European Research Projects on Mental Disorders", INSERM, CNRS and UPMC. The research teams of SEM, SJ, MM, JC-PV, BG and FB are members of the Bio-Psy Laboratory of Excellence; this work was therefore supported by French state funds managed by the ANR within the Investissements d'Avenir program under reference ANR-11-IDEX-0004-02. DYS was funded by the École des Neurosciences de Paris. This work was also supported by the City of Paris and Inserm Atip-Avenir to MM. FV was supported by grants from the Mission Interministérielle de Lutte contre la Drogue et la Toxicomanie (MILDT, 2006); the Département de la Recherche Clinique et du Développement-Assistance Publique Hôpitaux de Paris (DRCD-APHP,OST07013); and from the Programme Hospitalier de Recherches Cliniques (PHRC program,AOM10165). The Cellular Imaging and Flow Cytometry Facility is supported by the Conseil Régional Ile-de-France